Protein levels of human peroxiredoxin subtypes in brains of patients with Alzheimer's disease and Down Syndrome

Journal of Neural Transmission, Supplement

Volumn , Issue 61, 2001, Pages 223-235

  Kim, S H ^a   Fountoulakis, M ^b   Cairns, N ^c   Lubec, G ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ISOENZYME; MITOCHONDRIAL PROTEIN; PEROXIREDOXIN; ALKYL HYDROPEROXIDE REDUCTASE; PEROXIDASE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN LEVEL; BRAIN MITOCHONDRION; BRAIN NERVE CELL; BRAIN PROTECTION; BRAIN REGION; BRAIN TISSUE; CELL DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN SYNDROME; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION; BRAIN; ENZYMOLOGY; MASS SPECTROMETRY; METABOLISM; OXIDATIVE STRESS;

AGED; ALZHEIMER DISEASE; BRAIN; DOWN SYNDROME; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMAN; MIDDLE AGE; OXIDATIVE STRESS; PEROXIDASES; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SUPPORT, NON-U.S. GOV'T;

EID: 0035233637     PISSN: 03036995     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-7091-6262-0_18     Document Type: Article

References (59)

1. Adler V, Yin Z, Tew KD, Ronai Z (1999) Role of redox potential and reactive oxygen species in stress signaling. Oncogene 18: 222: 6104-6111
2. Araki M, Nanri H, Ejima K, Murasato Y, Fujiwara T, Nakashima Y, Ikeda M (1999) Antioxidant function of the mitochondrial protein SP-22 in the cardiovascular system. J Biol Chem 274: 2271-2278
3. Aylward EH, Habbak R, Warren AC, Pulsifer MB, Barta PE, Jerram M, Pearlson GD (1997) Cerebellar volume in adults with Down syndrome. Arch Neurol 54: 209-212
4. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254
5. Brugge K, Nichols S, Saitoh T, Trauner D (1999) Correlations of glutathione peroxidase activity with memory impairment in adults with Down syndromes. Biol Psychiatry 46: 1682-1689
6. Busciglio J, Yankner BA (1995) Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro. Nature 378: 776-779
7. Cairns NJ (1999) Neuropathology. J Neural Transm [Suppl] 57: 61-74
8. Chae HZ, Chung SJ, Rhee SG (1994a) Thioredoxin-dependent peroxide reductase from yeast. J Biol Chem 269: 27670-27678
9. Chae HZ, Robison K, Poole LB, Church G, Storz G, Rhee SG (1994b) Cloning and sequencing of thio-specific antioxidant from mammalian brain: alkyl hydroperoxide reductase and thio-specific antioxidant define a large family of antioxidant enzymes. Proc Natl Acad Sci USA 91: 7017-7021
10. Chae HZ, Kang SW, Rhee SG (1999) Isoforms of mammalian peroxiredoxin that reduce peroxides in presence of thioredoxin. Methods Enzymol 300: 219-226
11. Chen QM, Tu VC, Wu Y, Bahl JJ (2000) Hydrogen peroxide dose dependent induction of cell death or hypertrophy in cardiomyocytes. Arch Biochem Biophys 373: 242-248
12. de la Monte SM (1999) Molecular abnormalities of the brain in Down syndrome: relevance to Alzheimer's neurodegeneration. J Neural Transm [Suppl] 57: 1-19
13. Fountoulakis M, Langen H (1997) Identification of proteins by matrix-assisted laser desorption ionization-mass spectrometry following in-gel digestion in low-salt, non-volatile buffer and simplified peptide recovery. Anal Biochem 250: 153-156
14. Fullerton HJ, Ditelberg JS, Chem SF, Sarco DP, Chan PH, Epstein CJ, Ferriero DM (1998) Copper/zinc superoxide dismutase transgenic brain accumulates hydrogen peroxide after perinatal hypoxia ischemia. Ann Neurol 44: 357-364
15. Gerli G, Zenoni L, Locatelli GF, Mongiat R, Piattoni F, Orsini GB, Montagnani A, Gueli MR, Gualandri V (1990) Erythrocyte antioxidant system in Down syndrome. Am J Med Genet [Suppl] 7: 272-273
16. Greber S, Lubec G, Cairns N, Fountoulakis M (1999) Decreased levels of synaptosomal associated protein 25 in the brain of patients with Down syndrome and Alzheimer's disease. Electrophoresis 20: 928-934
17. Gutteridge JM (1994) Biological origin of free radicals and mechanisms of antioxidant protection. Chem Biol Interact 91: 133-140
18. Halliwell B (1999) Antioxidant defence mechanisms: from the beginning to the end (of the beginning). Free Rad Res 31: 261-272
19. Hayes JD, McLellan LI (1999) Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress. Free Rad Res 31: 273-300
20. Hoyt KR, Gallagher AJ, Hastings TG, Reynolds IJ (1997) Characterization of hydrogen peroxide toxicity in cultured rat forebrain neurons. Neurochem Res 22: 333-340
21. Ichimiya S, Davis JG, O'Rourke DM, Katsumata M, Greene MI (1997) Murine thioredoxin peroxidase delays neuronal apoptosis and is expressed in areas of the brain most susceptible to hypoxic and ischemic injury. DNA Cell Biol 16: 311-321
22. Jovanovic SV, Clements D, MacLeod K (1998) Biomarkers of oxidative stress are significantly elevated in Down syndrome. Free Radic Biol Med 25: 1044-1048
23. Kang SW, Baines I, Rhee SG (1998a) Characterization of a mammalian peroxiredoxin that contains one conserved cysteine. J Biol Chem 273: 6303-6311
24. Kang SW, Chae HZ, Seo MS, Kim K, Baines IC, Rhee SG (1998b) Mammalian peroxiredoxin isoforms can reduce hydrogen peroxide generated in response to growth factors and tumor necrosis factor-alpha. J Biol Chem 273: 6297-6302
25. Kanno S, Ishikawa M, Takayanagi M, Takayanagi Y, Sasaki M (1999) Exposure to hydrogen peroxide induces cell death via apoptosis in primary cultured mouse hepatocytes. Biol Pharm Bull 22: 1296-1300
26. Kim SH, Vlkolinsky R, Cairns N, Fountoulakis M, Lubec G (2001) The reduction of NADH: ubiquinone oxidoreductase 24-and 75-kDa subunits in brains of patients with Down syndrome and Alzheimer's disease. Life Sci 68: 2741-2750
27. Kim SH, Vlkolinsky R, Cairns N, Lubec G (2000) Decreased protein levels of complex III core protein 1 and complex V beta chain. Cell Mol Life Sci 57: 1810-1816
28. Kowaltowski AJ, Netto LES, Vercesi AE (1998) The thiol-specific antioxidant enzyme prevents mitochondrial permeability transition. J Biol Chem 273: 12766-12769
29. Langen H, Roder D, Juranville JF, Fountoulakis M (1997) Effect of protein application mode and acrylamide concentration on the resolution of protein spots separated by two-dimensional gel electrophoresis. Electrophoresis 18: 2085-2090
30. Langen H, Berndt P, Roder D, Cairns N, Lubec G, Fountoulakis M (1999) Two-dimensional map of human brain proteins. Electrophoresis 20: 907-916
31. McBride AG, Borutaite V, Brown GC (1999) Superoxide dismutase and hydrogen peroxide cause rapid nitric oxide breakdown, peroxynitrite production and subsequent cell death. Biochim Biophys Acta 1454: 275-288
32. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L (1991) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41: 479-486
33. Nagy Zs (1999) Mechanisms of neuronal death in Down's syndrome. J Neural Transm [Suppl] 57: 233-245
34. Okado-Matsumoto A, Matsumoto A, Fujii J, Taniguchi N (2000) Peroxiredoxin IV is a secretable protein with heparin-binding properties under reduced conditions. J Biochem 127: 493-501
35. Pappolla MA, Omar RA, Kim KS, Robakis NK (1992) Immunohistochemical evidence of oxidative [corrected] stress in Alzheimer's disease. Am J Pathol 140: 621-628
36. Percy ME, Dalton AJ, Markovic VD, McLachlan DR, Hummel JT, Rusk AC, Andrews DF (1990) Red cell superoxide dismutase, glutathione peroxidase and catalase in Down syndrome patients with and without manifestations of Alzheimer's disease. Am J Med Genet 35: 459-467
37. Perrin R, Briancon S, Jeandel C, Artur Y, Minn A, Penin F, Siest G (1990) Blood activity of Cu/Zn superoxide dismutase, glutathione peroxidase and catalase in Alzheimer's disease: a case-control study. Gerontology 36: 306-313
38. Pierce GB, Parchment RE, Lewellyn AL (1991) Hydrogen peroxide as a mediator of programmed cell death in the blastocyst. Differentiation 46: 181-186
39. Richter-Landsberg C, Vollgraf U (1998) Mode of cell injury and death after hydrogen peroxide exposure in cultured oligodendroglia cells. Exp Cell Res 244: 218-229
40. Sarafian TA, Rajper N, Grigorian B, Kim A, Shau H (1997) Cellular antioxidant properties of human natural killer enhancing factor B. Free Radic Res 26: 281-289
41. Sarafian TA, Huang C, Kim A, de Velli J, Shau H (1998) Expression of the antioxidant gene NKEF in the central nervous system. Mol Chem Neuropathol 34: 39-51
42. Sarafian TA, Verity MA, Vinters HV, Shih CC, Shi L, Ji XD, Dong L, Shau H (1999) Differential expression of peroxiredoxin subtypes in human brain cell types. J Neurosci Res 56: 206-212
43. Sauri H, Butterfield L, Kim A, Shau H (1995) Antioxidant function of recombinant human natural killer enhancing factor. Biochem Biophys Res Commun 208: 964-969
44. Sawa A (1999) Neuronal cell death in Down's syndrome. J Neural Transm [Suppl] 57: 87-97
45. Shau H, Kim A (1994) Identification of natural killer enhancing factor as a major antioxidant in human red blood cells. Biochem Biophys Res Commun 199: 83-88
46. Shau H, Gupta RK, Golub SH (1993) Identification of a natural killer enhancing factor (NKEF) from human erythroid cells. Cell Immunol 147: 1-11
47. Shau H, Kim AT, Hedrick CC, Lusis AJ, Tompkins C, Finney R, Leung DW, Paglia DE (1997) Endogenous natural killer enhancing factor-B increases cellular resistance to oxidative stresses. Free Radic Biol Med 22: 497-507
48. Simonian NA, Coyle JT (1996) Oxidative stress in neurodegenerative diseases. Annu Rev Pharmacol Toxicol 36: 83-106
49. Tierney MC, Fisher RH, Lewis AJ, Zorzitto ML, Snow WG, Reid DW, Nieuwstraten P (1988) The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease: a clinicopathologic study of 57 cases. Neurology 38: 359-364
50. Tsuji K, Copeland NG, Jenkins NA, Obinata N (1995) Mammalian antioxidant protein complements alkylhydroperoxide reductase (ahpC) mutation in Escherichia coli. Biochem J 307: 377-381
51. Vollgraf U, Wegner M, Richter-Landsberg C (1999) Activation of AP-1 and nuclear factor-kappaB transcription factors is involved in hydrogen peroxide-induced apoptotic cell death of oligodendrocytes. J Neurochem 73: 2501-2509
52. Watabe S, Kohno H, Kouyama H, Hiroi T, Yago N, Nakazawa T (1994) Purification and characterization of a substrate protein for mitochondrial ATP-dependent protease in bovine adrenal cortex. J Biochem (Tokyo) 115: 648-654
53. Watabe S, Hasegawa H, Takimoto K, Yamamoto Y, Takahashi SY (1995) Possible function of SP-22, a substrate of mitochondrial ATP dependent protease, as a radical scavenger. Biochem Biophys Res Commun 213: 1010-1016
54. Watabe S, Hiroi T, Yamamoto Y, Fujioka K, Hasegawa H, Yago N, Takahashi SY (1997) SP-22 is a thioredoxin-dependent peroxide reductase in mitochondria. Eur J Biochem 249: 52-60
55. Whittemore ER, Loo DT, Cotman CW (1994) Exposure to hydrogen peroxide induces cell death via apoptosis in cultured rat cortical neurons. Neuroreport 5: 1485-1488
56. Whittemore ER, Loo DT, Watt JA, Cotman CW (1995) A detailed analysis of hydrogen peroxide-induced cell death in primary neuronal culture. Neuroscience 67: 921-932
57. Yamamoto Y, Matsui Y, Natori S, Obinata M (1989) Cloning of a housekeeping-type gene (MER5) preferentially expressed in murine erythroleukemia cells. Gene 80: 337-343
58. Zang P, Liu B, Kang SW, Seo MS, Rhee SG, Obeid LM (1997) Thioredoxin peroxidase is a novel inhibitor of apoptosis with a mechanism distinct from that of Bcl-2. J Biol Chem 272: 30615-30618
59. Zhou Y, Kok KH, Chun AC, Wong CM, Wu HW, Lin MC, Fung PC, Kung H, Jin DY (2000) Mouse peroxiredoxin V is a thioredoxin peroxidase that inhibits p53-induced apoptosis. Biochem Biophys Res Commun 268: 921-927